These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 11586406)
1. Inhibitory effect of peptide vilon on the development of induced rat urinary bladder tumors in rats. Pliss GB; Mel'nikov AS; Malinin VV; Khavinson VK Bull Exp Biol Med; 2001 Jun; 131(6):558-60. PubMed ID: 11586406 [TBL] [Abstract][Full Text] [Related]
2. [Effect of vilon and epithalone on induction and growth of induced bladder neoplasms in rats]. Pliss GB; Mel'nikov AS; Malinin VV; Khavinson VKh Vopr Onkol; 2001; 47(5):601-7. PubMed ID: 11785104 [TBL] [Abstract][Full Text] [Related]
3. [The lithium carbonate promotion of urothelial tumors in rats induced with N-butyl-N-(4-hydroxybutyl)-nitrosamine]. Frolov AG; Pliss GB Vopr Onkol; 1992; 38(11):1309-13. PubMed ID: 1343160 [TBL] [Abstract][Full Text] [Related]
4. Lack of promotion of N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated urinary bladder carcinogenesis in mice by rat cancer promoters. Tamano S; Asakawa E; Boomyaphiphat P; Masui T; Fukushima S Teratog Carcinog Mutagen; 1993; 13(2):89-96. PubMed ID: 8102212 [TBL] [Abstract][Full Text] [Related]
5. Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Kitayama W; Denda A; Okajima E; Tsujiuchi T; Konishi Y Carcinogenesis; 1999 Dec; 20(12):2305-10. PubMed ID: 10590224 [TBL] [Abstract][Full Text] [Related]
6. Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats. Wanibuchi H; Yamamoto S; Chen H; Yoshida K; Endo G; Hori T; Fukushima S Carcinogenesis; 1996 Nov; 17(11):2435-9. PubMed ID: 8968060 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine. Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958 [TBL] [Abstract][Full Text] [Related]
8. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele. Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488 [TBL] [Abstract][Full Text] [Related]
9. [A model of rat's urinary bladder tumor induced by subcutaneous injection of N-butyl-N-(4-hydroxybutyl)-nitrosamine]. Pliss GB; Vlasov NN; Iogannsen MG; Frolov AG Vopr Onkol; 1998; 44(4):432-5. PubMed ID: 9807207 [TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers. Lubet RA; Fischer SM; Steele VE; Juliana MM; Desmond R; Grubbs CJ Int J Cancer; 2008 Nov; 123(10):2254-9. PubMed ID: 18712722 [TBL] [Abstract][Full Text] [Related]
11. Modification of N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated urinary bladder carcinogenesis in rats by phytic acid and its salts. Takaba K; Hirose M; Ogawa K; Hakoi K; Fukushima S Food Chem Toxicol; 1994 Jun; 32(6):499-503. PubMed ID: 8045454 [TBL] [Abstract][Full Text] [Related]
12. Promoting effect of monosodium aspartate, but not glycine, on renal pelvis and urinary bladder carcinogenesis in rat induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. Kitamura M; Konishi N; Kitahori Y; Fukushima Y; Yoshioka N; Hiasa Y Toxicol Pathol; 1996; 24(5):573-9. PubMed ID: 8923678 [TBL] [Abstract][Full Text] [Related]
13. Effects of intravesical instillation of antitumor chemotherapeutic and immunotherapeutic agents on bladder lesion development in rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Okamura T; Ohtani M; Inoue K; Fukushima S; Ohtaguro K; Kakizoe T J Urol; 1987 Nov; 138(5):1305-7. PubMed ID: 2444722 [TBL] [Abstract][Full Text] [Related]
14. Ethanol-extracted propolis enhances BBN-initiated urinary bladder carcinogenesis via non-mutagenic mechanisms in rats. Xie XL; Gi M; Fujioka M; Doi K; Yamano S; Tachibana H; Fang H; Kakehashi A; Wanibuchi H Food Chem Toxicol; 2015 Sep; 83():193-200. PubMed ID: 26111810 [TBL] [Abstract][Full Text] [Related]
15. Promoting effect of unilateral nephrectomy on urinary bladder carcinogenesis in rats. Saikawa S; Kanamaru H; Li B; Matsukawa S; Okada K Jpn J Cancer Res; 1996 Nov; 87(11):1121-4. PubMed ID: 9045940 [TBL] [Abstract][Full Text] [Related]
16. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis. Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018 [TBL] [Abstract][Full Text] [Related]
17. Bladder carcinogenesis in mice induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and N-ethyl-N-(4-hydroxybutyl)-nitrosamine with reference to the effect of cyclophosphamide. Numoto S; Yoshida M; Otsuka H Gan; 1981 Oct; 72(5):647-54. PubMed ID: 7327366 [TBL] [Abstract][Full Text] [Related]
18. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine. de Camargo JL; Shirai T; Kato T; Asamoto M; Fukushima S Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of the aqueous extract of Magnolia officinalis on the responses of human urinary bladder cancer 5637 cells in vitro and mouse urinary bladder tumors induced by N-Butyl-N-(4-hydroxybutyl) nitrosamine in vivo. Lee SJ; Cho YH; Park K; Kim EJ; Kang BS; Jung KH; Kim CH; Kim WJ; Moon SK Phytother Res; 2009 Jan; 23(1):20-7. PubMed ID: 19048611 [TBL] [Abstract][Full Text] [Related]
20. [Sodium nitrate as a possible promotor of bladder carcinogenesis in rats]. Pliss GB; Frolov AG Vopr Onkol; 1991; 37(2):203-6. PubMed ID: 2014701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]